151 related articles for article (PubMed ID: 31736240)
21. The phenotype of EZH2 haploinsufficiency-1.2-Mb deletion at 7q36.1 in a child with tall stature and intellectual disability.
Suri T; Dixit A
Am J Med Genet A; 2017 Oct; 173(10):2731-2735. PubMed ID: 28696078
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of NSD1 mutations in Sotos and Weaver syndromes.
Rio M; Clech L; Amiel J; Faivre L; Lyonnet S; Le Merrer M; Odent S; Lacombe D; Edery P; Brauner R; Raoul O; Gosset P; Prieur M; Vekemans M; Munnich A; Colleaux L; Cormier-Daire V
J Med Genet; 2003 Jun; 40(6):436-40. PubMed ID: 12807965
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic expansion and variable expressivity in individuals with JARID2-related intellectual disability: A case series.
Cadieux-Dion M; Farrow E; Thiffault I; Cohen ASA; Welsh H; Bartik L; Schwager C; Engleman K; Zhou D; Zhang L; Repnikova E; Amudhavalli SM; Saunders CJ
Clin Genet; 2022 Aug; 102(2):136-141. PubMed ID: 35533077
[TBL] [Abstract][Full Text] [Related]
24. An investigation of the etiology and follow-up findings in 35 children with overgrowth syndromes, including biallelic SUZ12 variant.
Yüksel Ülker A; Uludağ Alkaya D; Çağlayan AO; Usluer E; Aykut A; Aslanger A; Vural M; Tüysüz B
Am J Med Genet A; 2023 Jun; 191(6):1530-1545. PubMed ID: 36919607
[TBL] [Abstract][Full Text] [Related]
25. Mutations in SETD2 cause a novel overgrowth condition.
Luscan A; Laurendeau I; Malan V; Francannet C; Odent S; Giuliano F; Lacombe D; Touraine R; Vidaud M; Pasmant E; Cormier-Daire V
J Med Genet; 2014 Aug; 51(8):512-7. PubMed ID: 24852293
[TBL] [Abstract][Full Text] [Related]
26. The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.
Ostrowski PJ; Zachariou A; Loveday C; Beleza-Meireles A; Bertoli M; Dean J; Douglas AGL; Ellis I; Foster A; Graham JM; Hague J; Hilhorst-Hofstee Y; Hoffer M; Johnson D; Josifova D; Kant SG; Kini U; Lachlan K; Lam W; Lees M; Lynch S; Maitz S; McKee S; Metcalfe K; Nathanson K; Ockeloen CW; Parker MJ; Pierson TM; Rahikkala E; Sanchez-Lara PA; Spano A; Van Maldergem L; Cole T; Douzgou S; Tatton-Brown K
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):557-564. PubMed ID: 31721432
[TBL] [Abstract][Full Text] [Related]
27. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
[TBL] [Abstract][Full Text] [Related]
28. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
[TBL] [Abstract][Full Text] [Related]
29. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
[TBL] [Abstract][Full Text] [Related]
30. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
31. Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.
El Chehadeh S; Kerstjens-Frederikse WS; Thevenon J; Kuentz P; Bruel AL; Thauvin-Robinet C; Bensignor C; Dollfus H; Laugel V; Rivière JB; Duffourd Y; Bonnet C; Robert MP; Isaiko R; Straub M; Creuzot-Garcher C; Calvas P; Chassaing N; Loeys B; Reyniers E; Vandeweyer G; Kooy F; Hančárová M; Havlovicová M; Prchalová D; Sedláček Z; Gilissen C; Pfundt R; Wassink-Ruiter JSK; Faivre L
Eur J Hum Genet; 2016 Jan; 25(1):43-51. PubMed ID: 27804958
[TBL] [Abstract][Full Text] [Related]
32. Deregulated expression of polycomb repressive complex 2 target genes in a NF1 patient with microdeletion generating the RNF135-SUZ12 chimeric gene.
Tritto V; Grilli F; Milani D; Riva P
Neurogenetics; 2023 Jul; 24(3):181-188. PubMed ID: 37145209
[TBL] [Abstract][Full Text] [Related]
33. Growth pattern of Rahman syndrome.
Takenouchi T; Uehara T; Kosaki K; Mizuno S
Am J Med Genet A; 2018 Mar; 176(3):712-714. PubMed ID: 29383847
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome.
Vasileiou G; Vergarajauregui S; Endele S; Popp B; Büttner C; Ekici AB; Gerard M; Bramswig NC; Albrecht B; Clayton-Smith J; Morton J; Tomkins S; Low K; Weber A; Wenzel M; Altmüller J; Li Y; Wollnik B; Hoganson G; Plona MR; Cho MT; ; Thiel CT; Lüdecke HJ; Strom TM; Calpena E; Wilkie AOM; Wieczorek D; Engel FB; Reis A
Am J Hum Genet; 2018 Mar; 102(3):468-479. PubMed ID: 29429572
[TBL] [Abstract][Full Text] [Related]
35.
Tlemsani C; Luscan A; Leulliot N; Bieth E; Afenjar A; Baujat G; Doco-Fenzy M; Goldenberg A; Lacombe D; Lambert L; Odent S; Pasche J; Sigaudy S; Buffet A; Violle-Poirsier C; Briand-Suleau A; Laurendeau I; Chin M; Saugier-Veber P; Vidaud D; Cormier-Daire V; Vidaud M; Pasmant E; Burglen L
J Med Genet; 2016 Nov; 53(11):743-751. PubMed ID: 27317772
[TBL] [Abstract][Full Text] [Related]
36. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic Causes of Overgrowth Syndromes.
Lui JC; Baron J
J Clin Endocrinol Metab; 2024 Jan; 109(2):312-320. PubMed ID: 37450557
[TBL] [Abstract][Full Text] [Related]
38. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability.
Wijnen IGM; Veenstra-Knol HE; Vansenne F; Gerkes EH; de Koning T; Vos YJ; Tijssen MAJ; Sival D; Darin N; Vanhoutte EK; Oosterloo M; Pennings M; van de Warrenburg BP; Kamsteeg EJ
Eur J Hum Genet; 2020 Jun; 28(6):763-769. PubMed ID: 32157189
[TBL] [Abstract][Full Text] [Related]
39. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.
Tenorio J; Alarcón P; Arias P; Dapía I; García-Miñaur S; Palomares Bralo M; Campistol J; Climent S; Valenzuela I; Ramos S; Monseny AM; Grondona FL; Botet J; Serrano M; Solís M; Santos-Simarro F; Álvarez S; Teixidó-Tura G; Fernández Jaén A; Gordo G; Bardón Rivera MB; Nevado J; Hernández A; Cigudosa JC; Ruiz-Pérez VL; Tizzano EF; ; Lapunzina P
Eur J Hum Genet; 2020 Apr; 28(4):469-479. PubMed ID: 31685998
[TBL] [Abstract][Full Text] [Related]
40. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
